Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04761198
Title A Study of Etigilimab and Nivolumab in Subjects With Locally Advanced or Metastatic Tumors.
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Mereo BioPharma
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | GBR

Facility Status City State Zip Country Details
Mereo Investigator Site Phoenix Arizona 85054 United States Details
Mereo Investigator Site Greenbrae California 94904 United States Details
Mereo Investigator Site Los Angeles California 90025 United States Details
Mereo Investigator Site Jacksonville Florida 32224 United States Details
Mereo Investigator Site Boston Massachusetts 02215 United States Details
Mereo Investigator Site Ann Arbor Michigan 48109 United States Details
Mereo Investigator Site Rochester Minnesota 55905 United States Details
Mereo Investigator Site New York New York 10065 United States Details
Mereo Investigator Site Durham North Carolina 27710 United States Details
Mereo Investigator Site Oklahoma City Oklahoma 73104 United States Details
Mereo Investigator Site Nashville Tennessee 37203 United States Details
Mereo Investigator Site Houston Texas 77030 United States Details
Mereo Investigator Site West Valley City Utah 84119 United States Details
Mereo Investigator Site Fairfax Virginia 22031 United States Details
Royal Marsden London United Kingdom Details
Sarah Cannon UK London United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field